BG Medicine, Inc. was founded as Beyond Genomics, Inc. in 2000 by thought leaders in systems biology from Harvard, Purdue, Indiana, and Leiden (The Netherlands) Universities and by Flagship Ventures (Cambridge, MA).
BG Medicine has since gone on to develop and validate its advanced proprietary platform that uses an integrated approach to gene expression, proteomics and metabolomics to provide actionable insight in the effects of disease or treatment on intact animals or man. These profiles combine information from multiple physiological compartments and often include thousands of distinct analyte levels, thus enabling an unprecedented molecular characterization of disease states and drug responses. This enhanced insight in disease and drug effect form the basis for critical R&D decisions by global pharmaceutical corporations.
|